Zhang Jiao, Zhuo Zhen-Jian, Wang Jiaxiang, He Jing, Yang Lin, Zhang Da, Qin Pan, Yan Lizhao
Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, China.
Oncotarget. 2017 Aug 24;8(53):91343-91349. doi: 10.18632/oncotarget.20514. eCollection 2017 Oct 31.
In this case-control study, we analyzed the association between three single nucleotide polymorphisms (SNPs) in the gene (rs6939340 A>G, rs4712653 T>C, and rs9295536 C>A) and neuroblastoma susceptibility in the Guangdong and Henan populations of China. We genotyped and analyzed 118 cases and 281 control subjects from Henan province and combined them with previously published data from the Guangdong population. In the Henan population, only the rs6939340 G>A variant homozygote AA was associated with decreased neuroblastoma risk [AA vs. GG: adjusted odds ratio (OR) = 0.47, 95% confidence interval (CI) = 0.23-0.98; =0.045]. All three polymorphisms, individually and in combination, were associated with decreased neuroblastoma susceptibility in the Guangdong population. Moreover, subjects carrying 1-3 of these protective genotypes had lower neuroblastoma susceptibility than non-carriers (adjusted OR=0.65, 95% CI=0.51-0.84, =0.0007). These results show that all three genetic variants of identified in a genome-wide association study (GWAS) decrease neuroblastoma risk in two distinct Chinese populations.
在这项病例对照研究中,我们分析了该基因中的三个单核苷酸多态性(SNP,rs6939340 A>G、rs4712653 T>C和rs9295536 C>A)与中国广东和河南人群神经母细胞瘤易感性之间的关联。我们对来自河南省的118例病例和281名对照受试者进行基因分型和分析,并将其与先前发表的广东人群数据相结合。在河南人群中,只有rs6939340 G>A变异纯合子AA与神经母细胞瘤风险降低相关[AA与GG相比:调整后的优势比(OR)=0.47,95%置信区间(CI)=0.23 - 0.98;P = 0.045]。在广东人群中,这三种多态性单独或联合起来均与神经母细胞瘤易感性降低相关。此外,携带1 - 3种这些保护性基因型的受试者比非携带者具有更低的神经母细胞瘤易感性(调整后的OR = 0.65,95% CI = 0.51 - 0.84,P = 0.0007)。这些结果表明,在全基因组关联研究(GWAS)中鉴定出的该基因的所有三种遗传变异均降低了两个不同中国人群的神经母细胞瘤风险。